13 ALS Facts You Should Know About

ALS, or amyotrophic lateral sclerosis, also known as Lou Gehrig’s disease, is a progressive neurodegenerative disease that affects nerve cells in the brain and the spinal cord. A-myo-trophic comes from the Greek language. “A” means no. “Myo” is referring to the muscle, and “Trophic” means nourishment –…

ALS.net has just announced the launch of “ALS Unfiltered,” a series of public sessions that will offer expert-led presentations and open conversations about amyotrophic lateral sclerosis (ALS, or Lou Gehrig’s disease), current research status, clinical trials, resources and other topics. The seminars will be held in several cities…

https://www.youtube.com/watch?v=emZjNcD484E In this Comcast NewsmakersIL video, learn more about the Les Turner ALS Foundation. “Since 1977, the Les Turner ALS Foundation has been Chicagoland’s leader in patient services, research, and education for Amyotrophic Lateral Sclerosis (ALS). The foundation serves nearly 90% of people living with ALS in the Chicagoland…

Yumanity Therapeutics has recently licensed a prodrug invented at the University of Arizona (UA), adding it to the company’s expanding platform of potential therapies for neurodegenerative diseases like amyotrophic lateral sclerosis (ALS). Neurodegenerative diseases result from errors made during the building and folding processes of proteins within the cell. In 2009, UA…

In this video by The University of Edinburgh, watch Chen Zhao from the School of Clinical Sciences present her three minute thesis entitled “Astrocyte: the Star of Motor Neuron Disease”. Learn more about ALS here: https://bit.ly/ALSNewsToday…

In this MND Australia video, “Kirsten Harley speaks about her experience living with motor neurone disease at Parliament House, Canberra, 24 February 2016.” Learn more about ALS here: https://bit.ly/ALSNewsToday…

Herantis Pharma announced that it has received a positive opinion from the European Medicines Agency’s Committee for Orphan Medicinal Products (COMP) on its application for orphan drug designation for CDNF as a potential treatment for amyotrophic lateral sclerosis (ALS). A positive opinion is the first step toward orphan drug designation which, in…

“Professor Siddharthan Chandran is Director of the Euan MacDonald Centre for Motor Neurone Disease Research at the University of Edinburgh.” Learn more about ALS here: https://bit.ly/ALSNewsToday…

In this Embracing Life Through Love Inc. video, get to know more about the #beyondthebucket campaign, which has the “goal to help people learn more about what ALS actually is and the effect it has on the patients and families it effects.” Learn more about ALS here: https://bit.ly/ALSNewsToday…

The California Institute for Regenerative Medicine (CIRM)’s Independent Citizens Oversight Committee has approved a $6.3 million grant to fund a research team’s work into a new human embryonic stem cell-based therapy, involving astrocytes, to rescue and restore neurons damaged as a consequence of amyotrophic lateral sclerosis (ALS). Team members, from the University of…